MK801 influences l-DOPA-induced dopamine release in intact and hemi-parkinson rats

By Jonkers N.   Sarre S.   Ebinger G.   Michotte Y.  

European Journal of Pharmacology, Vol. 407, Iss. 3, 2000-11 ,pp. : 281-291

Elsevier

Access to resources Recommend Favorite

Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of l-dopa in hemi-Parkinson rats

By Izurieta-Sanchez P.   Sarre S.   Ebinger G.   Michotte Y.  

European Journal of Pharmacology, Vol. 353, Iss. 1, 1998-07 ,pp. : 33-42

Elsevier

Access to resources Recommend Favorite

Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat

By Silvestre J.S.   O'Neill M.F.   Fernandez A.G.   Palacios J.M.  

European Journal of Pharmacology, Vol. 318, Iss. 2, 1996-12 ,pp. : 257-265

Elsevier

Access to resources Recommend Favorite

Recent Advances in the Development of Dopamine D3 Receptor Agonists and Antagonists

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 1, 2001-05 ,pp. : 89-99

Bentham Science Publishers

Access to resources Recommend Favorite

Tolerability and Safety of Ropinirole versus Other Dopamine Agonists and Levodopa in the Treatment of Parkinson's Disease: Meta-Analysis of Randomized Controlled Trials

By Kulisevsky Jaime   Pagonabarraga Javier  

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 147-161

Adis International

Access to resources Recommend Favorite